Disc Medicine Insider Trade Surge: CEO Sells 33,000 Shares While Legal Officer Buys 7,500 at 20% of Market Price – A Mixed Signal of Confidence and Caution
Discover how Disc Medicine insiders’ buying and selling tactics reveal hidden confidence and potential risks in a stock with a high‑potential hematology pipeline.
3 minutes to read